US Patent 11643461 Humanized, mouse or chimeric anti-CD47 monoclonal antibodies
Patent 11643461 was granted and assigned to Forty Seven on May, 2023 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 11643461 Humanized, mouse or chimeric anti-CD47 monoclonal antibodies
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
